Jamie E. Chaft

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.768Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Regional and clonal T cell dynamics at single cell resolution in immune checkpoint blockade

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.27.461389

Top 38%

0.510DataRank

Top 38%6 citations

Andrew Chow, Jennifer L. Sauter, Marissa S. Mattar, Hira Rizvi, Hyung Jun Woo +21 more

Papers

Driven by 56 papers — median percentile 52. Top paper: “Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade”.

Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0047

N/A

7.6DataRank · unranked

340 citations

Jia Luo, Song Wu, Han Si, Chen Gao, Wenjing Xu +10 more

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

New England Journal of Medicine(2023)10.1056/nejmoa2302983

N/A

7.3DataRank · unranked

1056 citations

Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi, Se‐Hoon Lee, Shugeng Gao +14 more

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet(2024)10.1016/s0140-6736(24)01756-2

N/A

3.7DataRank · unranked

262 citations

Marina Chiara Garassino, Heather A. Wakelee, Moïshe Liberman, Terufumi Kato, Masahiro Tsuboi +91 more

Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.02.030

N/A

1.1DataRank · unranked

27 citations

Zachary Moore, Stephanie Lobaugh, Alexander Geyer, Daphna Y. Gelblum, Raja-Elie E. Abdulnour +23 more

Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1207

N/A

0.542DataRank · unranked

36 citations

Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M. Muldoon, Hira Rizvi, Arielle Elkrief +23 more

Regional and clonal T cell dynamics at single cell resolution in immune checkpoint blockade

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.27.461389

Top 38%

0.510DataRank

Top 38%6 citations

Andrew Chow, Jennifer L. Sauter, Marissa S. Mattar, Hira Rizvi, Hyung Jun Woo +21 more

Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation Trial

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.12.018

N/A

0.369DataRank · unranked

6 citations

Daphna Y. Gelblum, Abraham J. Wu, Annemarie F. Shepherd, Boris Mueller, Siyuan Zhang +17 more

Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100759

Top 59%

0.258DataRank

Top 59%4 citations

Andrea Arfè, Biagio Ricciuti, Andréanne Gagné, Lynette M. Sholl, Alessandro Di Federico +19 more

Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.10.012

N/A

0.208DataRank · unranked

3 citations

Jake June-Koo Lee, Noura J. Choudhury, Angela B. Hui, Mark Jeng, Jennifer Zheng +20 more

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Nature(2021)10.1038/s41586-021-03752-4

N/A

0DataRank · unranked

552 citations

Jiajia Zhang, Zhicheng Ji, Ajay Vaghasia, Boyang Zhang, Emily Han-Chung Hsiue +50 more

Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100187

N/A

0DataRank · unranked

33 citations

Jaime L. Schneider, Tejas Patil, Viola W. Zhu, Debra A. Goldman, Soo-Ryum Yang +13 more

Association Between the Early Discontinuation of Durvalumab and Poor Survival in Patients With Stage III NSCLC

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100197

N/A

0DataRank · unranked

25 citations

Michael Offin, Annemarie F. Shepherd, Matthew D. Hellmann, Daniel R. Gomez, Jamie E. Chaft +2 more

Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab

Radiotherapy and Oncology(2021)10.1016/j.radonc.2021.12.016

N/A

0DataRank · unranked

21 citations

Annemarie F. Shepherd, Isabel R. Preeshagul, Michael Offin, Daphna Y. Gelblum, Abraham J. Wu +9 more

Increasing Heart Dose Reduces Overall Survival in Patients Undergoing Postoperative Radiation Therapy for NSCLC

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100209

N/A

0DataRank · unranked

20 citations

Anthony F. Yu, Michelle Iocolano, Jonathan E. Leeman, Aaron T. Wild, Brandon S. Imber +13 more

The Impact of Durvalumab on Local-Regional Control in Stage III NSCLCs Treated With Chemoradiation and on KEAP1-NFE2L2-Mutant Tumors

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.04.019

N/A

0DataRank · unranked

16 citations

Michael Offin, Annemarie F. Shepherd, Charles B. Simone, Daphna Y. Gelblum, Abraham J. Wu +6 more

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Nature Medicine(2022)10.1038/s41591-022-02047-z

N/A

0DataRank · unranked

195 citations

Emily S. Lebow, Randy Yeh, Jeeban Paul Das, Azadeh Namakydoust, Paul K. Paik +67 more

Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004688

N/A

0DataRank · unranked

139 citations

Jenna VanLiere Canzoniero, Samuel Rosner, Guangfan Zhang, James R. White, Zineb Belcaid +22 more

Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions

The Journal of Experimental Medicine(2022)10.1084/jem.20212169

N/A

0DataRank · unranked

49 citations

Andrew Chow, Levi Mangarin, Heng Pan, Jiajia Zhang, Nicholas Ceglia +21 more

Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2022)10.1016/j.jtcvs.2022.10.007

N/A

0DataRank · unranked

41 citations

Alan Nicholas, G. Alexander Patterson, Salama N. Waqar, Eric M. Toloza, Eric B. Haura +24 more

Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors

Cancer Immunology Immunotherapy(2022)10.1007/s00262-022-03169-6

N/A

0DataRank · unranked

30 citations

Joell J. Gills, Fuad Mohammad, James R. White, Courtney Stevens, Hua Ding +15 more

Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas

Nature Communications(2022)10.1038/s41467-022-33719-6

N/A

0DataRank · unranked

19 citations

Jia Luo, Ni Ai, Rachel Kim, Linda S. Ahn, Anup Biswas +10 more

Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2022)10.1016/j.jtcvs.2022.10.056

N/A

0DataRank · unranked

9 citations

Junting Zheng, Kay See Tan, Corinne C. Liu, Bernard J. Park, Gaetano Rocco +12 more

Impact of TMB, PD-L1 expression, and pneumonitis on outcomes to chemoradiation and durvalumab in unresectable stage III non-small cell lung cancers

Research Square(2022)10.21203/rs.3.rs-2273813/v1

N/A

0DataRank · unranked

0 citations

Biagio Ricciuti, Xinan Wang, Giuseppe Lamberti, Arielle Elkrief, Federica Pecci +12 more

Efficacy of PD-(L)1 blockade monotherapy compared to PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study

medRxiv(2022)10.1101/2022.12.05.22283131

N/A

0DataRank · unranked

0 citations

Joao M. Victor Alessi, Biagio Ricciuti, Samantha Brown, Hira Rizvi, Isabel R. Preeshagul +16 more

Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade

Cancer Cell(2023)10.1016/j.ccell.2023.03.009

N/A

0DataRank · unranked

145 citations

Matthew D. Hellmann, Jennifer L. Sauter, Marissa S. Mattar, Hira Rizvi, Hyung Jun Woo +28 more

Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2994

N/A

0DataRank · unranked

69 citations

Joshua E. Reuss, Marianna Zahurak, Jiajia Zhang, Zhen Zeng, Janis M. Taube +12 more

Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0498

N/A

0DataRank · unranked

39 citations

Nicholas R. Waters, Natalie Smith, Anqi Dai, John Slingerland, Nathan Aleynick +24 more

Early-stage ALK-positive lung cancer: a narrative review

Translational Lung Cancer Research(2023)10.21037/tlcr-22-631

N/A

0DataRank · unranked

38 citations

Jamie E. Chaft, Monica F. Chen

Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC

Nature Communications(2023)10.1038/s41467-023-39874-8

N/A

0DataRank · unranked

30 citations

Biagio Ricciuti, Xinan Wang, Federica Pecci, Alessandro Di Federico, Giuseppe Lamberti +13 more

Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patients with Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab

JAMA Network Open(2023)10.1001/jamanetworkopen.2022.49591

N/A

0DataRank · unranked

23 citations

Annemarie F. Shepherd, Jordan Eichholz, Michael Offin, Daphna Y. Gelblum, Abraham J. Wu +9 more

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

Frontiers in Oncology(2023)10.3389/fonc.2023.1253629

N/A

0DataRank · unranked

18 citations

Narek Shaverdian, Jordan Eichholz, L.B. Kratochvil, Megan McCune, Yonina R. Murciano‐Goroff +27 more

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006994

N/A

0DataRank · unranked

14 citations

Joao V. Alessi, Biagio Ricciuti, Samantha Brown, Hira Rizvi, Isabel R. Preeshagul +16 more

Initial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.12.022

N/A

0DataRank · unranked

14 citations

Michelle Sanchez, Elinton Lee, Hans J. Hertzler, Nhi M. Luong, Emanuele Mazzola +17 more

Lung resection after initial nonoperative treatment for non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2023)10.1016/j.jtcvs.2023.11.040

N/A

0DataRank · unranked

13 citations

Cameron N. Fick, Kay See Tan, Nicolas Toumbacaris, Brooke Mastrogiacomo, Prasad S. Adusumilli +15 more

Superior sulcus non–small cell lung cancers (Pancoast tumors): Current outcomes after multidisciplinary management

Journal of Thoracic and Cardiovascular Surgery(2023)10.1016/j.jtcvs.2023.08.023

N/A

0DataRank · unranked

11 citations

Kay See Tan, Joseph Dycoco, Monica F. Chen, Jamie E. Chaft, Nikhil P. Mankuzhy +14 more

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

Radiotherapy and Oncology(2023)10.1016/j.radonc.2023.109983

N/A

0DataRank · unranked

9 citations

Kelly Fitzgerald, Aditya Apte, Jung Hun Oh, Aditi Iyer, Otasowie Odiase +12 more

Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007618

N/A

0DataRank · unranked

8 citations

Adam Price, Allison L. Richards, Biagio Ricciuti, Xinan Wang, Arielle Elkrief +14 more

Data from Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non–Small Cell Lung Cancer

(2023)10.1158/1078-0432.c.6533117.v1

N/A

0DataRank · unranked

0 citations

Joshua E. Reuss, Marianna Zahurak, Jiajia Zhang, Zhen Zeng, Janis M. Taube +12 more

Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9107

N/A

0DataRank · unranked

0 citations

Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M. Muldoon, Jia Luo, Joao Victor Machado Alessi +13 more

A Novel FDG PET and Mean Lung Dose Model to Identify Stage III NSCLC Patients at High Risk of Developing Early Radiation Pneumonitis

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.271

N/A

0DataRank · unranked

0 citations

Annemarie F. Shepherd, Aditya Apte, Daphna Y. Gelblum, Abraham J. Wu, Charles B. Simone +6 more

High-risk features associated with recurrence in stage I lung adenocarcinoma

Journal of Thoracic and Cardiovascular Surgery(2024)10.1016/j.jtcvs.2024.05.009

N/A

0DataRank · unranked

40 citations

Elizabeth G. Dunne, Stijn Vanstraelen, Nicolas Toumbacaris, Kay See Tan, Gaetano Rocco +13 more

The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer

The Annals of Thoracic Surgery(2024)10.1016/j.athoracsur.2024.01.024

N/A

0DataRank · unranked

35 citations

Cameron N. Fick, James M. Isbell, Jamie E. Chaft, Nasser K. Altorki, Bernard J. Park +13 more

Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS- Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2983

N/A

0DataRank · unranked

14 citations

Sydney Connor, Khaled Sanber, Marianna Zahurak, Tianbei Zhang, Isha Gurumurthy +24 more

Induction therapy for non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2024)10.1016/j.jtcvs.2024.01.048

N/A

0DataRank · unranked

5 citations

Jamie E. Chaft, Matthew J. Bott, Alissa J. Cooper

Association of the time of day of chemoradiotherapy and durvalumab with tumor control in lung cancer

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110658

N/A

0DataRank · unranked

3 citations

Annemarie F. Shepherd, Alissa J. Cooper, Adam J. Schoenfeld, Abraham J. Wu, Charles B. Simone +6 more

Clinicopathologic and genomic features associated with brain metastasis after resection of lung adenocarcinoma

JTCVS Open(2024)10.1016/j.xjon.2024.09.030

N/A

0DataRank · unranked

2 citations

Cameron N. Fick, Brooke Mastrogiacomo, Kay See Tan, Nicolas Toumbacaris, Stijn Vanstraelen +13 more

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001282

N/A

0DataRank · unranked

166 citations

Valsamo Anagnostou, Tricia R. Cottrell, Kellie N. Smith, Franco Verde, Marianna Zahurak +27 more

Thymus Composition Predicts Pneumonitis Risk in Lung Cancer Therapy

medRxiv(2025)10.1101/2025.10.27.25338565

N/A

0DataRank · unranked

0 citations

Gokul Krishnan, Kwadwo Amoako-Boadu, Abraham J. Book, David Miller, Biniam A. Garomsa +8 more

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.005

N/A

0DataRank · unranked

460 citations

Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf +38 more

COVID-19 in patients with lung cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.06.007

N/A

0DataRank · unranked

270 citations

Hira Rizvi, Isabel R. Preeshagul, Jacklynn V. Egger, David Hoyos, Chai Bandlamudi +26 more

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3418

N/A

0DataRank · unranked

123 citations

Barzin Y. Nabet, Hira Rizvi, Aadel A. Chaudhuri, Daniel K. Wells, Mark Dunphy +30 more

Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab

Radiotherapy and Oncology(2020)10.1016/j.radonc.2020.04.047

N/A

0DataRank · unranked

56 citations

Narek Shaverdian, Andreas Rimner, Stephanie Lobaugh, Annemarie F. Shepherd, Charles B. Simone +10 more

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab

Cancer Medicine(2020)10.1002/cam4.3113

N/A

0DataRank · unranked

64 citations

Maria Thor, Annemarie F. Shepherd, Michael Offin, Andrew Jackson, Abraham J. Wu +9 more

Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors

Annals of Oncology(2020)10.1016/j.annonc.2020.09.016

N/A

0DataRank · unranked

52 citations

Jason Beattie, Maria Thor, Michael Offin, Annemarie F. Shepherd, Daphna Y. Gelblum +7 more

Clinical and Dosimetric Predictors of Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation Therapy

Practical Radiation Oncology(2020)10.1016/j.prro.2020.09.014

N/A

0DataRank · unranked

22 citations

Michelle Iocolano, Jonathan E. Leeman, Brandon S. Imber, Aaron T. Wild, Michael Offin +11 more

ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps9077

N/A

0DataRank · unranked

31 citations

Sumithra J. Mandrekar, Geoffrey R. Oxnard, David Kozono, Shauna L. Hillman, Suzanne E. Dahlberg +13 more

Jamie E. Chaft

Indexed papers

Top data-sharing exemplar

Papers